Royal Bank of Canada Has $18.34 Million Stock Position in Hawkins, Inc. $HWKN

Posted by Stanley Muller on Aug 7th, 2026

Royal Bank of Canada boosted its stake in shares of Hawkins, Inc. (NASDAQ:HWKN – Free Report) by 3.7% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 119,368 shares of the specialty chemicals company’s stock after purchasing an additional 4,274 shares during the quarter. Royal Bank of Canada owned 0.57% of Hawkins worth $18,335,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Vanguard Group Inc. raised its position in shares of Hawkins by 1.4% during the fourth quarter. Vanguard Group Inc. now owns 1,525,789 shares of the specialty chemicals company’s stock valued at $216,754,000 after buying an additional 20,958 shares during the last quarter. State Street Corp raised its holdings in Hawkins by 11.6% in the 4th quarter. State Street Corp now owns 1,067,451 shares of the specialty chemicals company’s stock valued at $151,642,000 after acquiring an additional 111,318 shares in the last quarter. Wasatch Advisors LP lifted its position in shares of Hawkins by 31.4% in the 4th quarter. Wasatch Advisors LP now owns 552,419 shares of the specialty chemicals company’s stock worth $78,477,000 after acquiring an additional 131,850 shares during the period. Geode Capital Management LLC increased its position in shares of Hawkins by 2.8% during the fourth quarter. Geode Capital Management LLC now owns 513,535 shares of the specialty chemicals company’s stock valued at $72,965,000 after purchasing an additional 13,828 shares during the period. Finally, Capital World Investors raised its stake in shares of Hawkins by 34.4% in the fourth quarter. Capital World Investors now owns 477,985 shares of the specialty chemicals company’s stock valued at $67,903,000 after purchasing an additional 122,366 shares in the last quarter. 69.71% of the stock is currently owned by institutional investors and hedge funds.

Hawkins Stock Performance

NASDAQ:HWKN opened at $130.03 on Friday. The stock has a market capitalization of $2.72 billion, a P/E ratio of 33.69, a price-to-earnings-growth ratio of 2.79 and a beta of 0.79. The company has a current ratio of 2.27, a quick ratio of 1.54 and a debt-to-equity ratio of 0.45. Hawkins, Inc. has a 1 year low of $117.98 and a 1 year high of $186.15. The firm has a 50 day moving average of $146.58 and a 200-day moving average of $149.32.

Hawkins (NASDAQ:HWKN – Get Free Report) last posted its quarterly earnings data on Wednesday, July 29th. The specialty chemicals company reported $1.35 EPS for the quarter, missing analysts’ consensus estimates of $1.39 by ($0.04). Hawkins had a return on equity of 15.42% and a net margin of 7.29%.The business had revenue of $315.68 million during the quarter, compared to analyst estimates of $313.42 million. As a group, sell-side analysts anticipate that Hawkins, Inc. will post 4.04 EPS for the current fiscal year.

Hawkins Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, August 28th. Shareholders of record on Friday, August 14th will be given a $0.19 dividend. This represents a $0.76 annualized dividend and a yield of 0.6%. The ex-dividend date is Friday, August 14th. Hawkins’s dividend payout ratio (DPR) is presently 19.69%.

Hawkins News Roundup

Here are the key news stories impacting Hawkins this week:

Positive Sentiment: Sidoti made modest upward revisions to its EPS forecasts for Q2 2027, Q1 2028 and Q2 2028, indicating some expected strength in those periods. Sidoti’s FY2028 forecast remains a substantial $5.00 per share despite recent quarterly reductions. Hawkins analyst estimates
Neutral Sentiment: Sidoti’s estimates imply FY2027 EPS of $4.20 and FY2028 EPS of $5.00, providing investors with a framework for longer-term earnings growth. However, these figures are analyst projections and remain subject to changes in chemical demand, pricing and operating costs. Hawkins earnings estimates
Negative Sentiment: Zacks Research downgraded Hawkins from “hold” to “strong sell,” a notably bearish change that likely weighed on investor confidence. Zacks Research report
Negative Sentiment: Sidoti cut its FY2027 EPS forecast to $4.20 from $4.45 and its FY2028 forecast to $5.00 from $5.35. It also reduced estimates for Q3 2027, Q4 2027, Q3 2028 and Q4 2028, signaling weaker expected earnings momentum in several periods. Sidoti Hawkins estimates
Negative Sentiment: The company’s latest quarterly results also showed an EPS miss, with reported earnings of $1.35 per share versus the $1.39 consensus estimate. Against this backdrop, downward revisions and the “strong sell” rating reinforce concerns that Hawkins’ current valuation may not fully reflect near-term earnings risks.

Analyst Upgrades and Downgrades

A number of equities research analysts have weighed in on HWKN shares. Weiss Ratings downgraded shares of Hawkins from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Tuesday, July 14th. BWS Financial reissued a “buy” rating and issued a $200.00 target price on shares of Hawkins in a research note on Monday. Zacks Research downgraded Hawkins from a “hold” rating to a “strong sell” rating in a report on Tuesday. Finally, Barclays set a $142.00 target price on Hawkins and gave the stock an “equal weight” rating in a report on Friday, July 31st. One investment analyst has rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $171.00.

Get Our Latest Stock Report on HWKN

About Hawkins

(Free Report)

Hawkins, Inc (NASDAQ: HWKN) is a specialty chemical company that produces and distributes water-treatment and industrial chemicals across North America. Founded in 1938 and headquartered in Roseville, Minnesota, the company has built a network of manufacturing facilities and distribution centers that serve municipal, industrial and commercial customers. As a publicly traded entity, Hawkins leverages its long-standing presence in the chemical distribution industry to provide tailored solutions for complex water-treatment challenges and specialty chemical needs.

Hawkins’ product portfolio encompasses a wide range of chemicals, including sodium hypochlorite, sodium hydroxide, hydrogen peroxide, chlorine, acids and specialty blends.